Kidney cancer research highlights from ASCO GU 2025
Every year, researchers from around the world gather at a [...]
Patient engagement is a potential blockbuster treatment that urologists should prescribe for their cancer patients
This presentation at the European Association of Urology (EAU) Annual [...]
Patient-reported outcomes with nivolumab plus cabozantinib in advanced kidney cancer
Ongoing results from the phase 3 CheckMate-9ER clinical trial with nivolumab plus cabozantinib have been [...]
Patient-reported outcomes with atezolizumab plus bevacizumab in metastatic kidney cancer
This study describes patient-reported outcomes from the phase 3 IMmotion151 [...]
Atezolizumab alone or in combination with bevacizumab for untreated metastatic kidney cancer
This paper reports patient-reported outcomes from the phase 2 IMmotion150 [...]
Research supports better integration of patient voice in health technology assessments
A report from Myeloma UK and the National Institute for [...]
Data-driven approach to personalised care
One of the greatest strengths of the NHS is its [...]
Patient reported experience for patients with kidney cancer
In this video interview from Practice Update, Dr Eric Jonasch, [...]
ASCO GU 2019: Patient perspectives on cytoreductive nephrectomy after CARMENA
The following survey assessed patient views related to cytoreductive nephrectomy [...]
Patient-reported outcomes for atezolizumab plus bevacizumab combination
Patient-reported outcomes from the phase 3 IMmotion151 study, which assessed [...]
